TRV

Third Rock Ventures Portfolio holdings

AUM $1.07B
1-Year Est. Return 201.55%
This Quarter Est. Return
1 Year Est. Return
+201.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$961M
AUM Growth
+$23.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5
New
Increased
Reduced
Closed

Top Buys

1
+$196M

Top Sells

1
+$237M
2
+$73M
3
+$34.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAGE
1
DELISTED
Sage Therapeutics
SAGE
$640M 66.66%
8,773,073
-1,000,000
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$196M 20.38%
+7,393,059
LRMR icon
3
Larimar Therapeutics
LRMR
$332M
$111M 11.54%
266,837
-83,333
CARM
4
DELISTED
Carisma Therapeutics
CARM
$13.7M 1.42%
242,080
FMI
5
DELISTED
Foundation Medicine, Inc.
FMI
– –
-4,927,234